Pedro Cabrales Selected Research

Hemodilution

1/2013	Improving cardiac function with new-generation plasma volume expanders.
1/2013	Plasma expander and blood storage effects on capillary perfusion in transfusion after hemorrhage.
1/2012	Exogenous intravascular nitric oxide enhances ventricular function after hemodilution with plasma expander.
12/2010	Tissue oxidative metabolism after extreme hemodilution with PEG-conjugated hemoglobin.
8/2010	Perfusion vs. oxygen delivery in transfusion with "fresh" and "old" red blood cells: the experimental evidence.
1/2010	Cardiac mechanoenergetic cost of elevated plasma viscosity after moderate hemodilution.
8/2008	Oxygen transport during hemodilution with a perfluorocarbon-based oxygen carrier: effect of altitude and hyperoxia.
1/2008	Survival time in severe hemorrhagic shock after perioperative hemodilution is longer with PEG-conjugated human serum albumin than with HES 130/0.4: a microvascular perspective.
10/2007	Resuscitation from hemorrhagic shock with hydroxyethyl starch and coagulation changes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pedro Cabrales Research Topics

Disease

38	Hemorrhagic Shock 01/2021 - 10/2004
33	Neoplasms (Cancer) 01/2022 - 07/2014
24	Hypoxia (Hypoxemia) 01/2022 - 11/2003
21	Hemorrhage 01/2021 - 11/2004
17	Shock 01/2021 - 11/2004
13	Inflammation (Inflammations) 09/2022 - 06/2011
13	Anemia 04/2021 - 08/2006
10	Hypertension (High Blood Pressure) 01/2020 - 11/2006
8	Reperfusion Injury 01/2022 - 02/2007
8	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 01/2016
7	Infections 09/2022 - 06/2011
7	Ischemia 01/2020 - 02/2007
6	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021 - 02/2015
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 01/2016
5	Wounds and Injuries (Trauma) 01/2020 - 10/2007
5	Cerebral Malaria 05/2015 - 03/2010
4	Lung Neoplasms (Lung Cancer) 11/2021 - 01/2016
4	Stroke (Strokes) 01/2019 - 01/2010
4	Malaria 07/2016 - 05/2015
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2016 - 09/2015
4	Hyperoxia 01/2012 - 10/2003
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2019
3	Hemolysis 01/2022 - 01/2017
3	Neoplasm Metastasis (Metastasis) 11/2021 - 01/2017
3	Necrosis 04/2021 - 01/2015
3	Sepsis (Septicemia) 01/2021 - 01/2006
3	Endotoxemia 01/2021 - 01/2006
3	Hypovolemia 11/2013 - 10/2007
2	COVID-19 09/2022 - 10/2020
2	Lung Injury 04/2022 - 05/2020
2	Atherosclerosis 01/2021 - 01/2019
2	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2009
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 01/2020
2	Edema (Dropsy) 01/2021 - 12/2020
2	Septic Shock (Toxic Shock Syndrome) 01/2021 - 01/2011
2	Cardiotoxicity 12/2019 - 01/2019
2	Obesity 01/2019 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2008
2	Pain (Aches) 06/2018 - 09/2015
2	Thrombosis (Thrombus) 11/2013 - 10/2007

Drug/Important Bio-Agent (IBA)

47	Oxygen (Dioxygen)IBA 01/2022 - 10/2003
32	RRx-001IBA 01/2022 - 01/2015
29	Hemoglobins (Hemoglobin)IBA 01/2022 - 10/2004
19	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2022 - 01/2006
9	AlbuminsIBA 01/2022 - 10/2004
8	PlatinumIBA 01/2021 - 01/2016
8	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 05/2015
7	Human Serum Albumin FDA LinkGeneric 01/2022 - 10/2004
7	SolutionsIBA 01/2021 - 11/2004
6	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 01/2016
6	NitritesIBA 01/2019 - 12/2009
6	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 02/2015 - 10/2004
6	Starch (Cornstarch)IBA 11/2013 - 11/2004
5	LipopolysaccharidesIBA 04/2022 - 01/2006
5	Pharmaceutical PreparationsIBA 01/2022 - 05/2016
5	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 01/2016
4	Colloids (Colloid)IBA 01/2021 - 10/2007
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2008
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2016
3	Heme (Haem)IBA 01/2021 - 05/2015
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
3	Dextrans (Dextran)FDA Link 01/2021 - 01/2006
3	Blood Substitutes (Artificial Blood)IBA 01/2020 - 06/2013
3	polymerized bovine hemoglobinIBA 01/2020 - 03/2009
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2018 - 08/2015
3	FluorocarbonsIBA 04/2011 - 02/2007
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 07/2020
2	CytokinesIBA 04/2021 - 01/2019
2	AntibodiesIBA 04/2021 - 06/2011
2	AntioxidantsIBA 01/2021 - 08/2019
2	IronIBA 01/2021 - 05/2020
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2017
2	GBT1118IBA 01/2021 - 08/2017
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
2	Bosentan (Tracleer)FDA Link 10/2020 - 01/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019 - 01/2019
2	Hormones (Hormone)IBA 01/2019 - 01/2016
2	Sickle HemoglobinIBA 01/2018 - 11/2006
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 01/2016
2	Endothelin Receptors (Endothelin Receptor)IBA 01/2018 - 08/2015
2	antineoplaston A10 (A 10)IBA 02/2017 - 07/2011
2	Sodium NitriteIBA 01/2017 - 12/2009
2	Nitric Oxide Synthase (NO Synthase)IBA 08/2016 - 01/2013
2	Carboplatin (JM8)FDA LinkGeneric 01/2016 - 01/2016
2	Artemether FDA Link 05/2015 - 03/2010
2	Carbon MonoxideIBA 09/2012 - 02/2007
2	Glutathione (Reduced Glutathione)IBA 06/2012 - 06/2009
2	EmulsionsIBA 04/2011 - 02/2007
2	salicylhydroxamic acid (SHAM)IBA 06/2009 - 10/2007
2	Bovine Serum AlbuminIBA 01/2006 - 07/2005
2	AlginatesIBA 06/2005 - 11/2004

Therapy/Procedure

35	Resuscitation 01/2021 - 10/2004
16	Therapeutics 11/2021 - 12/2009
10	Blood Transfusion (Blood Transfusions) 01/2020 - 08/2010
9	Hemodilution 01/2013 - 10/2007
8	Drug Therapy (Chemotherapy) 11/2021 - 01/2016
4	Radiotherapy 01/2017 - 07/2014
3	Aftercare (After-Treatment) 04/2021 - 01/2016
2	Catheters 01/2019 - 06/2017
2	Lasers (Laser) 11/2013 - 10/2007